The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
A BMJ international panel made up of women living with HIV, specialist doctors, and general practitioners recommends non-tenofovir based treatment regimes for pregnant women living with HIV.
In the era of treat all, renewed emphasis is needed on the 39% of people living with HIV who start treatment late who are at an increased risk of deaths and opportunistic infections.
In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older
There has been a vast decline in mortality among people with HIV who get on antiretroviral treatment – but who are we leaving behind?
Weaker health systems and psychosocial factors may explain the differences in adherence patterns between Asia and Africa, the world’s two most HIV-affected regions.
HIV criminalisation is a growing global issue that is threatening effective HIV prevention, treatment and support, according to a new report from the HIV Justice Network and the Global Network of People Living with HIV (GNP+).
A study in the United States has found that people living with HIV aged 45 to 65, who start treatment with low CD4 counts – a measure of how healthy the immune system is – have higher mortality rates than their younger counterparts. Improved health outcomes were experienced among this group when treatment was started earlier, at the World Health Organisation recommended CD4 count of 500 cells/mm3.
HIV infection, or inflammatory changes associated with HIV infection, are responsible for fat gain in people living with HIV (PLHIV) and on treatment, and not the antiretroviral treatment (ART) itself. This is according to new research presented at the Conference on Retroviruses and Opportunistic Infections (CROI) last week.
Smoking is the biggest contributing factor to the total burden of non-AIDS related cancers for people living with HIV (PLHIV) in the United States, when compared to all other risk factors. Studies show that PLHIV who smoke, or used to smoke, have a 37 percent increased risk of non-AIDS related cancers in comparison to a control group, and a 29 percent increased risk when lung cancer is not taken into the equation. Halting the progression of HIV to AIDS could prevent another up to eight percent of non-AIDS cancer.